Investments in overdose antidote reversed approximately 1,500 overdoses last year, $700K investment will provide treatment for 1,000 residents of South and West Sides CHICAGO—(ENEWSPF)–July 21, 2017. Mayor Rahm Emanuel announced progress and investments in the City’s ongoing efforts to combat the opioid epidemic and improve health. Building on the success[Read More…]
Science
FDA Clears First Neonatal Magnetic Resonance Imaging Device
Silver Spring, Maryland–(ENEWSPF)–July 21, 2017. Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU). “Although we can use traditional MRI scanners to image neonates, taking babies outside of the neonatal intensive[Read More…]
Center for American Progress Releases State-by-State Medicaid Enrollment by Age, Gender, Race, Ethnicity
Washington, D.C. —(ENEWSPF)–July 20, 2017. Dismantling the Medicaid program is at the heart of President Donald Trump and congressional Republicans’ agenda—and the devastating Medicaid cuts proposed in their attempts to repeal the Affordable Care Act are a critical flashpoint in health care negotiations. President Trump has proposed cutting Medicaid by half in his budget. Yet new analysis from[Read More…]
#TimStrong: Officer Tim Jones Inaugural First Responders Street Dance
Park Forest, IL-(ENEWSPF)- The Park Forest American Legion will hold a street dance fundraiser to benefit Officer Tim Jones. The event will take place on Saturday, August 12, 2017 at 1631 South Western Avenue, Chicago Heights. The Officer Timothy Jones Inaugural First Responders Street Dance will begin at 9:00 a.m.[Read More…]
FDA Approves Vosevi for Treatment of Hepatitis C
Solver Spring, Maryland–(ENEWSPF)–July 18, 2017. The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose, combination tablet containing two previously approved drugs – sofosbuvir and velpatasvir – and[Read More…]
New CDC Report: More than 100 Million Americans Have Diabetes or Prediabetes
Diabetes growth rate steady, adding to health care burden Atlanta, GA–(ENEWSPF)–July 18, 2017. More than 100 million U.S. adults are now living with diabetes or prediabetes, according to a new report released today by the Centers for Disease Control and Prevention (CDC). The report finds that as of 2015, 30.3[Read More…]
CDC Awards $12 Million to Help States Fight Opioid Overdose Epidemic
Support will strengthen state efforts to prevent and track opioid overdoses Atlanta, GA–(ENEWSPF)–July 17, 2017. The Centers for Disease Control and Prevention (CDC) will be awarding this week more than $12 million to 23 states and the District of Columbia to support their responses to the opioid overdose epidemic. The[Read More…]
NIH Findings Link Aldosterone with Alcohol Use Disorder
Bethesda, Maryland–(ENEWSPF)–July 17, 2017. A new study led by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, demonstrates that aldosterone, a hormone produced in the adrenal glands, may contribute to alcohol use disorder (AUD). The novel research, conducted in collaboration[Read More…]
Federal Court Rejects Trump Administration’s Attempt to Dismiss Case Challenging Offshore Fracking in California
LOS ANGELES—(ENEWSPF)–July 17, 2017. A federal court on Friday rejected the Trump administration’s effort to dismiss a lawsuit challenging the approval of fracking in federal waters off California. The suit — filed by the Center for Biological Diversity and Wishtoyo Foundation — notes that the government violated the National Environmental[Read More…]
Study: Cannabinoids Reduce Migraine Frequency
Amsterdam, the Netherlands–(ENEWSPF)–July 14, 2017. The prolonged daily administration of cannabinoids is associated with a reduction in migraine headache frequency, according to clinical trial data presented at the 3rd Congress of the European Academy of Neurology. Italian researchers compared the efficacy of oral cannabinoid treatments versus amitriptyline – an anti-depressant[Read More…]
